Drug intelligence / Profile preview

e-viniferin

Development stage
Preclinical
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

**e-viniferin** is a naturally occurring dimer of resveratrol, classified as a stilbenoid polyphenol and found primarily in Vitis vinifera (grapevine) and grape-derived products. It exhibits a range of biological activities, including potent antioxidant, anti-inflammatory, cardioprotective, neuroprotective, anticancer, anti-angiogenic, anti-obesity, antimicrobial, and antifungal properties[3][5][7]. e-viniferin strongly inhibits multiple cytochrome P450 enzymes (notably CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP3A4, CYP4A, CYP2E1) with Ki values in the sub- to low-micromolar range[1][2]. It also inhibits angiotensin-converting enzyme (ACE)[5], and has been shown to enhance endogenous antioxidant enzyme activity and modulate key metabolic and inflammatory signaling pathways including SIRT3/AMPK/FOXO3, and arginase/NO production[3]. e-viniferin is extensively metabolized, mainly by glucuronidation, and has low oral bioavailability[5]. It is being considered for use as a nutraceutical and as an ingredient in functional foods, but is not developed as a pharmaceutical drug.

Other names
epsilon-Viniferinε-viniferin(-)-trans-ε-viniferin(-)-epsilon-Viniferin
02

Targets

CYP2C19 (Cytochrome P450 2C19)CYP1B1 (Cytochrome P450 1B1)CYP4A (Cytochrome P450 4A family)CYP1A2 (Cytochrome P450 1A2)CYP3A4 (Cytochrome P450 3A4)CYP2B6 (Cytochrome P450 2B6)CYP2E1CYP1A1 (Cytochrome P450 1A1)CYP2A6 (Cytochrome P450 2A6)

Beyond the preview

Go deeper on e-viniferin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on e-viniferin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call